Recursion (NASDAQ: RXRX)
Salt Lake City, US · 8 known investors
Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
AI & Machine LearningBiotechData & InfrastructureDeep TechMedical Devicesin /4990022@recursionpharma
Founders & leadership
CG
Chris GibsonCo-founder, Chairman of the Board
Investors · 8
Lux Capital✓ verifiedNew York · $100K – $100M
DCVC (Data Collective)✓ verifiedPalo Alto · $5M – $25M
Air Street CapitalSt. Peter Port · $500K – $10M
Amplify PartnersMenlo Park · $500K – $5M
CRV (Charles River Ventures)Bay Area · $250K – $5M
Felicis VenturesSan Francisco · $500K – $15M
Menlo VenturesSan Francisco · $1M – $20M
Necessary VenturesSan Francisco · $1M – $2M